Johnson & Johnson’s “Talcum” Two-Step
December 12, 2024
Allegra Abramson, postdoctoral fellow at Temple Law’s Center for Compliance & Ethics, explores the most recent talcum lawsuit against Johnson & Johnson.
Bankruptcy
What Rescheduling Could Mean For Cannabis Bankruptcies
July 15, 2024
Duane Morris’ Lawrence J. Kotler, Seth A. Goldberg (LAW ‘99) and Ryan Spengler discuss the effect rescheduling cannabis might have on cannabis company bankruptcies.
Supreme Court Blocks the Misuse of Bankruptcy Code in Purdue Pharma Case, Delaying Relief for Opioid Victims
July 3, 2024
Douglas Sasso (LAW ’26) recaps the Supreme Court’s Harrington v. Purdue Pharma, L.P., discusses the Bankruptcy Code and the case’s impact to victims of the opioid crisis.
Courts Issuing Increasing Number of Distressed Real Estate Decisions
July 1, 2024
Though interest rates may have peaked, #FaegreDrinker’s Joseph N. Argentina Jr. (LAW ’09) and Andrew C. Kassner continue to expect a large volume of distressed real estate debtors to utilize the bankruptcy system over the next several years. Two recent decisions demonstrate the state of distressed real estate bankruptcies. Both pit the rights of real estate lenders against the proceeds of collateral other than the real estate itself.
Too big to fail – Spring semester business law students learned how the rise and fall of railroads pioneered a path to deal with large-scale corporate bankruptcies
June 17, 2024
Douglas Sasso (LAW ’26) shares a spotlight on a Spring 2024 Current Topics in Business Law course which covered the influence railroads had on the development of the American legal system. Focusing on the Penn Central bankruptcy, the course offered students a chance to study what was once the largest merger and bankruptcy in history and its affect on legal, regulatory, and economic systems.
Navigating Distress: Alvarez & Marsal at Temple Law
June 7, 2024
Alvarez & Marsal partners, Ray Dombrowski (LAW ’79, LLM ’82) and Erin McKeighan discussed restructuring and turnaround work at Temple Law, highlighting the firm’s global leadership and emphasis on trust in revitalizing distressed businesses.
Purdue Pharma and the Sacklers: Unraveling Bankruptcy’s Third-Party Release Debate
May 9, 2024
Jasnoor Hundal, a third-year law student at Temple Law, examines the Purdue Pharma bankruptcy and its pending Supreme Court appeal, exploring the discrepancies among circuit courts and the absence of clear statutory guidance concerning nonconsensual third-party releases.
Third Circuit Rules Examiner Mandatory in FTX Bankruptcy
March 5, 2024
Temple Law Professor Jonathan C. Lipson discusses the Third Circuit’s decision in the FTX bankruptcy, ordering an independent examiner to investigate various issues at FTX, including potential conflicts of interest with Sullivan & Cromwell.
10-Q&A Episode 16: Bankruptcy for Billionaires: Purdue Pharma
Professor Jonathan Lipson and Charlotte Bismuth, author of Bad Medicine, discuss the Purdue Pharma bankruptcy and the challenges it presents for both the legal system and people who were harmed by OxyContin. Interviewer: Professor Jonathan Lipson, Harold E. Kohn Chair Guest: Charlotte Bismuth, author of Bad Medicine and former prosecutor for the New York County
The Bomb and the Bankruptcy
Award-winning Author Beth Macy at Temple Law School to discuss the opioid crisis with a panel of experts, including host Professor Jonathan Lipson.